Bromocriptine for the treatment of postoperative cerebellar mutism syndrome in pediatric patients: Three case reports.
Miguel Ángel Amor-GarcíaCecilia M Fernández-LlamazaresSilvia Manrique-RodríguezÁlvaro Narrillos-MorazaMarina García-MorínJorge HuertaMaría Sanjurjo-SáezPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
Bromocriptine has shown to be an effective and safe treatment for CMS in pediatric patients after posterior fossa tumor resection.
Keyphrases